International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Meloxicam 1% Topical Gel

Author(s): Allen Loyd V Jr

Issue: May/Jun 2017 - Volume 21, Number 3
View All Articles in Issue

Page(s): 235

Download in electronic PDF format for $75

Abstract: A formulation for preparing Meloxicam 1% Topical Gel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: meloxicam, formulation, topical preparation, anti-inflammatory agent, inflammation, analgesia, analgesic, pain relief

Related Categories: FORMULATIONS, PAIN MANAGEMENT, ALLERGY/IMMUNOLOGY/INFLAMMATION, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Meloxicam 1% Topical Gel Allen Loyd V Jr	May/Jun 2017 Pg. 235
Meloxicam 0.3% Topical Gel Allen Loyd V Jr	May/Jun 2008 Pg. 264
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin	Sep/Oct 2015 Pg. 357-365
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso	Mar/Apr 2021 Pg. 146-155
Ketorolac Tromethamine 2% Topical Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 544
Piroxicam 1% Soft-Patch Topical Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 72
Meloxicam 0.2 mg/mL Oral Liquid, Veterinary Allen Loyd V Jr	May/Jun 2005 Pg. 228
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Zugerman Jessie Jean M, Reed Thomas C	Nov/Dec 2007 Pg. 514-519
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Cyclosporine Topical Gel Formulation Allen Loyd V Jr	Jul/Aug 2023 Pg. 320-321
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Allen Loyd V Jr	Nov/Dec 2010 Pg. 520
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Zur Eyal	Nov/Dec 2012 Pg. 462-469
Return to Top